“GerdQ Questionnaire and PPI Test with Rabeprazole: High Diagnostic Value for Early Detection and Treatment of GERD in Coronary Heart Disease and Hypertension Patients”

https://pubmed.ncbi.nlm.nih.gov/38112351

The study found that a combination of a GerdQ questionnaire and a PPI test with Rabeprazole has a high diagnostic value for early detection and effective treatment of gastroesophageal reflux disease (GERD) in patients with coronary heart disease and essential arterial hypertension.